USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Arysta Lifescience Benelux SPRL

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).

5
Total patents granted
4
CPC technology areas
11.4
Avg claims per patent
-
5-year filing velocity

The verdict

Arysta holds 5 US patents across 4 technology areas, rank #44,620 of 50,000 tracked assignees.

#44,620
of 50,000 US assignees by volume
Top 85%
by Innovation Score (24.5/100)
11.4
avg claims per patent

Portfolio overview

Arysta Lifescience Benelux SPRL has been granted 5 US utility patents between 2020 and 2023, placing Arysta Lifescience Benelux SPRL at rank #44,620 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, Arysta Lifescience Benelux SPRL is one of the more focused assignees in the PatentsView dataset. By volume, Arysta sits between ARTS (5 patents, rank #44,616) and Asahi Shipping Co., Ltd. (5 patents, rank #44,624) - the closest US assignees by grant volume. The composite Innovation Score of 24.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Arysta Lifescience Benelux SPRL's 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Arysta Lifescience Benelux SPRL against peers pursuing similar technology classes.

Who files at Arysta's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arysta holds 5 patents at rank #44,620, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arysta

By rank, the assignees closest to #44,620 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Arysta's primary technology class.

Arysta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

25 Top 85% higher than 15% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2020202120222023 1
USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Arysta Lifescience Benelux SPRL patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 20.0%
2021 2 40.0%
2022 1 20.0%
2023 1 20.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple

Where it ranks

Overall rank by patents

#44,620

Across all tracked assignees

Innovation Score

24.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Arysta Lifescience Benelux SPRL hold?
Arysta Lifescience Benelux SPRL holds 5 US granted patents filed between 2020 and 2023, spanning 4 technology areas.
What is Arysta Lifescience Benelux SPRL's Innovation Score?
Arysta Lifescience Benelux SPRL has an Innovation Score of 24.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Arysta Lifescience Benelux SPRL focus on?
Arysta Lifescience Benelux SPRL's top technology area is A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS) with 5 patents. The company has filed patents in 4 CPC subclasses total.
Is Arysta Lifescience Benelux SPRL's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Arysta Lifescience Benelux SPRL.
What does claim depth mean for Arysta Lifescience Benelux SPRL's patents?
Arysta Lifescience Benelux SPRL's patents average 11.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Arysta Lifescience Benelux SPRL patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Arysta's 5 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Arysta ranks #44,620 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A01N - see who else leads that technology area. A01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.